Advanced Vesicular Systems for Antifungal Drug Delivery

Shaimaa Mosallam1, Rofida Albash2, Manar Adel Abdelbari3

  • 1Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, October 6 University, Giza, 12585, Egypt. shaimaamosallam@o6u.edu.eg.

AAPS Pharmscitech
|July 27, 2022
PubMed

Insights

Advanced vesicular carriers enhance antifungal drug efficacy and safety for opportunistic fungal infections. These biocompatible systems improve drug stability, solubility, and bioavailability, overcoming limitations of conventional treatments.

Area of Science:

  • Mycology and Pharmaceutical Sciences
  • Drug Delivery Systems
  • Biocompatible Materials

Background:

  • Fungal infections are a growing global health concern, particularly affecting immunocompromised individuals.
  • Opportunistic fungi like Candida, Fusarium, and Aspergillus species cause diverse infections, ranging from superficial to systemic.
  • Conventional antifungal drugs often exhibit poor physicochemical properties, high toxicity, and significant systemic side effects.

Purpose of the Study:

  • To review advanced vesicular carrier systems for encapsulating antifungal drugs.
  • To explore how these carriers improve drug efficacy and reduce adverse effects.
  • To address challenges in stability, solubility, bioavailability, and safety associated with antifungal therapies.

Main Methods:

  • Literature review of advanced vesicular drug delivery systems.
  • Analysis of biocompatible carriers for antifungal drug encapsulation.
  • Evaluation of carrier impact on drug physicochemical properties and therapeutic outcomes.

Main Results:

  • Vesicular carriers demonstrate potential for enhanced encapsulation of antifungal agents.
  • These systems can significantly improve drug solubility, stability, and bioavailability.
  • Biocompatible carriers show promise in reducing systemic toxicity and improving the safety profile of antifungals.

Conclusions:

  • Advanced vesicular carriers offer a promising strategy to overcome limitations of conventional antifungal treatments.
  • These drug delivery systems can enhance the therapeutic efficacy and safety of antifungal medications.
  • Further research into biocompatible vesicular carriers is warranted for improved management of fungal infections.

Related Concept Videos

Drug Delivery: Overview01:16

Drug Delivery: Overview

The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
402
Drug Delivery: Miscellaneous Routes01:22

Drug Delivery: Miscellaneous Routes

Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection,  and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
458
Drug Delivery: Parenteral Route01:29

Drug Delivery: Parenteral Route

The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
793
Mechanisms of Drug Absorption: Paracellular, Transcellular, and Vesicular Transport01:23

Mechanisms of Drug Absorption: Paracellular, Transcellular, and Vesicular Transport

Drugs need to permeate cell membranes to reach their target sites after administration. Orally administered drugs must transcend intestinal epithelial membrane barriers to infiltrate the systemic circulation. Drugs with a molecular weight of less than 500 Daltons diffuse through gaps between neighboring cells, called paracellular pathways.
However, most drugs use the transcellular route, traversing directly through the cell membranes via two mechanisms: passive and active transport. Passive...
756
Non-Oral Extravascular Drug Absorption Routes01:15

Non-Oral Extravascular Drug Absorption Routes

Non-oral extravascular routes, which encompass sublingual, buccal, topical, intramuscular, and inhalation methods, primarily utilize passive diffusion to transport drugs into the systemic circulation. The absorption rates and effectiveness of these routes depend on the drug's physicochemical properties, as well as the patient's anatomical and pathophysiological state.
Lipophilic drugs that are stable at salivary pH (6) and exhibit minimal binding to the oral mucosa are absorbed more...
280
Routes of Drug Administration: Parenteral01:25

Routes of Drug Administration: Parenteral

The administration of drugs via parenteral routes allows for direct drug introduction into the systemic circulation, resulting in high bioavailability because the medication bypasses the harsh conditions of the gastrointestinal tract and hepatic metabolism.
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...
2.1K